Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct;14(5):386-94.
doi: 10.1007/s11894-012-0277-1.

Clinical implications of enteroadherent Escherichia coli

Affiliations
Review

Clinical implications of enteroadherent Escherichia coli

Margarita M P Arenas-Hernández et al. Curr Gastroenterol Rep. 2012 Oct.

Abstract

Pathogenic Escherichia coli that colonize the small intestine primarily cause gastrointestinal illness in infants and travelers. The main categories of pathogenic E. coli that colonize the epithelial lining of the small intestine are enterotoxigenic E. coli, enteropathogenic E. coli, and enteroaggregative E. coli. These organisms accomplish their pathogenic process by a complex, coordinated multistage strategy, including nonintimate adherence mediated by various adhesins. These so called "enteroadherent E. coli" categories subsequently produce toxins or effector proteins that are either secreted to the milieu or injected to the host cell. Finally, destruction of the intestinal microvilli results from the intimate adherence or the toxic effect exerted over the epithelia, resulting in water secretion and diarrhea. In this review, we summarize the current state of knowledge regarding these enteroadherent E. coli strains and the present clinical understanding of how these organisms colonize the human intestine and cause disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1. ETEC-, EPEC- and EAEC-induced diarrhea is a multi-factorial event leading to disruption of ion/H2O balance
(A) In an ETEC infection, the LT toxin (A1 subunit) catalyzes the ADP-ribosylation of the α-subunit of Gs-protein, resulting in activation of adenylate cyclase and increased levels of intracellular cAMP. The activation of the cAMP-dependent A kinase results in phosphorylation of apical membrane transporters (i.e., the cystic fibrosis transmembrane conductance regulator, CFTR), resulting in secretion of Cl and HCO3 and decrease absorption of Na+ and Cl. STa acts by binding to the GC-C membrane receptor. Activation of GC-C results in increased levels of intracellular cGMP, elevated Cl secretion and decreased Na absorption, due to activation of cGMP-dependent kinase (G-kinase) and/or the cAMP dependent kinase (A-kinase). (B) EPEC infection decreases epithelial ion absorption resulting in diarrhea as a result of the bacterial protein effectors secreted by the type III secretion system (TTSS) having an effect on Cl and Na+ ion activity. Some TTSS secreted proteins Esps) affecting ion balances are: EspF, inhibiting function of Na+/H+ exchange isoform 3 (NH3); EspG, disrupting microtubules and leading to decrease in apical Cl/HCO3 exchange activity. EPEC, via unknown effector molecules decrease butyrate (But) absorption and induced activation of protein tyrosine phosphatases (PTPases). This results in decreasing function of serotonin transporter (SERT) and increasing prostaglandin E -2 (PGE-2) and 5-hydroxytryptamine 5-HT) availability, further affecting ion absorption and motility, resulting in diarrhea. (C) EAEC produces two plasmid-encoded toxins, the E. coli heat stable enterotoxin (EAST) and the plasmid encoded-toxin (Pet). Further, the chromosomally-encoded protein involved in colonization (Pic) (not shown), the Shigella enterotoxin 1 (ShET1) and hemolysin E (HlyE) are also produced. Although several toxins are secreted by EAEC, the mechanism of action associated with the EAEC-mediated diarrheal disease has not been fully established but involves G-kinase and A-kinase-dependent mechanism.

Similar articles

Cited by

References

    1. Torres AG, Zhou X, Kaper JB. Adherence of Diarrheagenic Escherichia coli Strains to Epithelial cells. Infect Immun. 2005;73:18–29. - PMC - PubMed
    1. Kaper JB, Nataro JP, Mobley HLT. Pathogenic Escherichia coli. Nat Rev Microbiol. 2004;2:123–140. - PubMed
    1. WHO. Future Directions for Research on Enterotoxigenic Escherichia coli Vaccines for Developing Countries. Wkly Epidemiol Rec. 2006;81:97–104. - PubMed
    1. Wang M, Szucs TD, Steffen R. Economic aspects of travelers’ diarrhea. J Travel Med. 2008;15:110–118. - PubMed
    1. Qadri F, Saha A, Ahmed T, Al Tarique A, Begum YA, Svennerholm AM. Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh. Infect Immun. 2007;75:3961–3968. - PMC - PubMed

Publication types

MeSH terms